USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SCOUT DIAGNOSTICS
Address:
404 CLYDEBANK COURT
LOUISVILLE, KY 40243-1805
Phone:
N/A
URL:
N/A
EIN:
120500932
DUNS:
614763006
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $208,025.00 2
STTR Phase II $951,836.00 1

Award List:

Commercialization of a Diagnostic Test for Alzheimer's Disease

Award Year / Program / Phase:
2010 / STTR / Phase II
Award Amount:
$951,836.00
Agency:
HHS
Principal Investigator:
Mark A. Lovell – 859-257-1412
Research Institution:
University Of Kentucky
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The major barriers to preventing or treating Alzheimer's disease (AD) are its unknown pathogenesis/etiology and the lack of an objective, sensitive and specific biomarker of the disease, particularly at the early stageswhen therapeutic interventions would… More

Development of a Plasma Biomarker of Alzheimer's Disease

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$99,090.00
Agency:
HHS
Principal Investigator:
Mark A. Lovell – 859-257-1412
Research Institution:
UNIVERSITY OF KENTUCKY
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The major barriers to preventing or treating Alzheimer's disease (AD) are its unknown pathogenesis/etiology and the lack of an objective, sensitive and specific biomarker of the disease, particularly at the early stageswhen therapeutic interventions would… More